Minimally Invasive Electro-Septal Myectomy (MESM)
MESM expands to minimally invasive electro septal myectomy.[1]
The MESM programme page names Zhejiang Provincial People’s Hospital in Hangzhou, China.[1]
This review documents one MESM centre worldwide, which is a documented-centre count rather than a market total.[1]
Names readers may encounter
- Chinese professional reporting pairs 微创室间隔电切术 with MESM.[6]
- In the MESM literature, minimally invasive septal myectomy uses sternum-sparing right infra-axillary access rather than a catheter-only route.[2]
- Transaortic septal myectomy via right infra-axillary incision is the title terminology of the 148-patient cohort.[2]
- The MESM programme describes the operation as a modified transaortic Morrow procedure.[1]
- 微创Morrow术 appears as Chinese shorthand on a public physician profile.[7]
- Classical septal myectomy removes thickened septal muscle during open-heart surgery to relieve obstruction.[8]
- Alcohol septal ablation is a catheter-based septal-reduction procedure rather than MESM.[5]
Procedure explanation
MESM is described as a modified Morrow procedure performed through a five-centimetre right infra-axillary incision in the third intercostal space with electrocautery.[1]
Candidacy boundaries
The 100-patient MESM cohort enrolled people with symptomatic hypertrophic obstructive cardiomyopathy that remained refractory to medical therapy.[3]
The AHA and ACC guideline says septal-reduction therapy must be performed at experienced hypertrophic-cardiomyopathy centres.[4]
The guideline says septal-reduction therapy should not be performed in asymptomatic patients with normal exercise capacity.[9]
Five-option comparison
| Option | Who it suits | Evidence | Key risks | Reversibility | What changes the decision |
|---|---|---|---|---|---|
| Full sternotomy myectomy | Associated cardiac disease needing surgery C48 | Established surgical route at experienced centres C27, C33 | UNESTABLISHED here | UNESTABLISHED | Need for concomitant cardiac surgery C48 |
| MESM | Study population: symptomatic obstructive HCM refractory to medication C32 | Single-centre retrospective cohorts C37–C41 | Pacemaker implantation and reported in-hospital death C42, C43 | UNESTABLISHED | Sternum-sparing access weighed against absent randomised comparison C31, C46 |
| Alcohol septal ablation | Eligible patients when surgery is contraindicated C48 | Guideline-recognised catheter route C28, C48 | Targeted myocardial cell death C49 | UNESTABLISHED | Surgical contraindication C48 |
| Medical therapy including myosin inhibitors | Clinician-directed stepwise therapy C47 | Guideline pathway C47 | UNESTABLISHED here | UNESTABLISHED | Persistence of symptoms after medication trials C47 |
| Postponement / no intervention | Asymptomatic with normal exercise capacity C34 | Monitoring and non-intervention boundary C34, C36A, C36B | Disease progression remains possible C50 | UNESTABLISHED | Symptoms, exercise capacity, imaging or rhythm findings change |
Evidence and overlap
The 148-patient series enrolled consecutive patients treated from September 2021 through July 2023 at one centre.[2]
Funding: UNESTABLISHED in the checked display.
Conflicts: UNESTABLISHED in the checked display.
The 100-patient series enrolled consecutive patients treated from November 2023 through May 2024 at one centre.[3]
PubMed lists Zhejiang provincial research support for the 100-patient paper and reports that its authors disclosed no conflicts of interest.[3]
The reported enrolment windows do not overlap, so the two cohorts are independent by patient dates but not independent external confirmation.[10]
Shared authors: Shuwei Wang, Zhiqiang Dong, Zhifang Liu, Erlei Han, Changhao Wu, Chentao Luo, Weikang Chen, Fuyang Mei, Xiaofeng Lu, Meijuan Yan, Zhenzhen Wang, Bing Zhou and Yong Cui.
The 100-patient cohort reported a mean left-ventricular-outflow-tract gradient change from 85.8 to 8.4 millimetres of mercury after surgery.[3]
Study-cohort pattern only; not a personal forecast.
Material risks
In the 148-patient cohort, eight patients received permanent pacemakers and one patient died in hospital after an intraoperative subarachnoid haemorrhage.[2]
In the 100-patient cohort, four patients received permanent pacemakers, while no in-hospital death or iatrogenic ventricular-septal defect was reported.[3]
Randomised comparisons of MESM against sternotomy myectomy have not been performed.[1]
Recovery and follow-up
The 148-patient study reported a mean hospital stay of 9.7 days with a standard deviation of 4.9 days.[2]
The 148-patient report described only early results and called for continued long-term follow-up.[10]
The guideline recommends repeating transthoracic echocardiography every one to two years or sooner when clinical status changes.[4]
The guideline includes a twelve-lead electrocardiogram in initial and annual follow-up and recommends twenty-four to forty-eight hours of ambulatory monitoring.[4]
Alternatives and postponement
The guideline places beta-blockers first and lists myosin inhibitors, disopyramide, or septal-reduction therapy when symptoms persist after medication trials.[4]
The guideline recommends surgical myectomy when associated cardiac disease also requires surgery and allows alcohol septal ablation when surgery is contraindicated.[4]
Alcohol septal ablation uses ethanol to make the targeted septal cells die and the thickened tissue shrink.[5]
Hypertrophic cardiomyopathy can worsen over time and may lead to atrial fibrillation, stroke, heart failure, or sudden cardiac arrest.[5]
Clinic dossier
Location and programme
Country: China
Documented city: Hangzhou
Guangzhou: UNESTABLISHED
Documented centres worldwide: 1 documented centre; not a market total.
Bookimed relationship: NO PUBLIC RELATIONSHIP FOUND
Eligibility packet
- Recent transthoracic echocardiography with gradients and SAM assessment
- Cardiac CT or MRI where available
- Clinical summary
- Current medication list
The guideline recommends coronary angiography before septal-reduction therapy.[4]
Aftercare and access
Aftercare/rescue owner: UNVERIFIED
International intake: UNVERIFIED
Languages: UNVERIFIED
Expected local stay: UNVERIFIED
Cross-border follow-up: UNVERIFIED
Bounded team

Source: 心脏外科崔勇医生 via Sohu
Yong Cui, MD, PhD
PubMed affiliates Yong Cui with the Heart Center and Department of Cardiovascular Surgery at Zhejiang Provincial People’s Hospital in Hangzhou.[3]
A professional training report states that Yong Cui demonstrated MESM during live surgical teaching.[11]
The MESM programme names Yong Cui as its cardiac surgeon and technique creator.[1]
PERSONALLY_OPERATING D3 Access UNVERIFIED
Zhenzhen Wang, MD
The MESM programme names Wang Zhenzhen in echocardiography and diagnosis.[1]
CENTRE_PARTICIPATION D1
Meijuan Yan, MD
The MESM programme names Yan Meijuan in anaesthesia and ultra-fast-track care.[1]
CENTRE_PARTICIPATION D1
Records and questions
- Bring the complete echocardiography files, not only a written summary.
- Add cardiac CT or MRI when available.
- List current and previously tried medicines.
- Ask which anatomy drives the obstruction.
- Request the named operator and accountable perioperative team.
- Ask for centre-specific contemporary outcomes.
- Agree who owns routine follow-up, urgent complications and records transfer.
FAQ by procedure name
What does MESM mean?
MESM means minimally invasive electro septal myectomy.[1]
What is Minimally Invasive Electro-Septal Myectomy?
Minimally Invasive Electro-Septal Myectomy is a transaortic surgical myectomy using right infra-axillary access and electrocautery-assisted resection.[3]
What does minimally invasive septal myectomy mean here?
Here, minimally invasive septal myectomy means sternum-sparing access through the right infra-axillary chest wall.[2]
What is transaortic septal myectomy via right infra-axillary incision?
It is the predecessor cohort’s title term for the same access route later labelled MESM.[2]
Is MESM a modified Morrow procedure?
The programme describes MESM as a modified transaortic Morrow procedure.[1]
What does 微创室间隔电切术 refer to?
微创室间隔电切术 is the documented Chinese name paired with MESM.[6]
What does 微创Morrow术 mean?
微创Morrow术 is Chinese shorthand used for minimally invasive Morrow surgery.[7]
What is surgical septal myectomy or the Morrow operation?
Classical surgical septal myectomy removes obstructing septal muscle during open-heart surgery.[8]
Is alcohol septal ablation the same as MESM?
Alcohol septal ablation is a distinct catheter-based procedure.[5]
Trust and review status
Review date: 30 August 2026
Last guideline check: 30 August 2026
Last regulator check: 30 August 2026
Clinical reviewer: NOT_ASSIGNED · human review task open
Sources
- MESM programme, technique, team and referral requirements
- JTCVS Techniques cohort
- PubMed MESM cohort record
- ACC HCM guideline key points
- American Heart Association HCM overview
- Chinese MESM terminology report
- Chinese physician profile
- Cleveland Clinic septal myectomy overview
- AHA/ACC guideline slide deck
- Publisher cohort page and limitations
- Professional training report
- Public portrait source
How this guide was prepared
Prepared by: bookimed_ai — Automated research and publishing account.
Bookimed medical governance contact: Fahad Mawlood — Medical Editor & Data Scientist. See the linked profile for role details. This identifies an organization-level role and does not mean this person personally reviewed this page.
Last updated . See Bookimed’s editorial policy and Medical Advisory Board.